{
    "nct_id": "NCT02996240",
    "official_title": "A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)",
    "inclusion_criteria": "* At least 18 years of age\n* ECOG â‰¤2\n* Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee\n* Consented for tissue collection on CTRC repository 07-32\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
    "exclusion_criteria": "* Active systemic illness (infection including viral illnesses such as Hepatitis and HIV)\n* Chronic use of NSAIDs or omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days)\n* Any NSAIDs or omega-3 free fatty acid supplementation within the last 14 days\n* History of medical noncompliance\n* Scheduled date of surgical resection that would limit the amount of time taking the intervention to less than 21 days",
    "miscellaneous_criteria": ""
}